CBS2024
CBS 2024 will focus on the cutting-edge academic content including Intervention for Complex Coronary Lesions, Pulmonary Hypertension, Heart Failure, Basic and Clinical Research Training.
Results:
Date/Time
Room
Session
Name
Role
Presentation Title
10:00 am-12:20 pm,
Saturday, November 29, 2025
730A
Shao-Liang Chen Moderator
10:00 am-12:20 pm,
Saturday, November 29, 2025
730A
Feng Chen Moderator
10:00 am-12:20 pm,
Saturday, November 29, 2025
730A
Francesco Lavarra Discussant
10:00 am-12:20 pm,
Saturday, November 29, 2025
730A
Teguh Santoso Discussant
10:00 am-12:20 pm,
Saturday, November 29, 2025
730A
Afzalur Rahman Discussant
10:00 am-12:20 pm,
Saturday, November 29, 2025
730A
Afsar Raza Discussant
10:00 am-12:20 pm,
Saturday, November 29, 2025
730A
Sasko Kedev Discussant
10:00 am-12:20 pm,
Saturday, November 29, 2025
730A
Tak W Kwan Discussant
10:00 am-12:20 pm,
Saturday, November 29, 2025
730A
Jun Luo Discussant
10:00 am-12:20 pm,
Saturday, November 29, 2025
730A
Lijun Liu Discussant
10:00 am-12:20 pm,
Saturday, November 29, 2025
730A
Changyu Wang Discussant
10:00 am-12:20 pm,
Saturday, November 29, 2025
730A
Kang Cheng Discussant
10:00 am-12:20 pm,
Saturday, November 29, 2025
730A
Dong Wang Discussant
10:00 am-12:20 pm,
Saturday, November 29, 2025
730A
Haoyu Wu Discussant
10:00 am-12:20 pm,
Saturday, November 29, 2025
730A
Xiang Chen Discussant
10:00 am-12:20 pm,
Saturday, November 29, 2025
730A
Yongtai Gong Discussant
10:00 am-10:20 am,
Saturday, November 29, 2025
730A
Nailiang Tian Speaker IVI-DIABETES Protocol
10:40 am-11:00 am,
Saturday, November 29, 2025
730A
Jing Kan Speaker IVI-DIABETES Statistical Analysis Plan
11:20 am-11:40 am,
Saturday, November 29, 2025
730A
Nuonan Gao Speaker Recommendations for IVI-guidance
11:40 am-11:50 am,
Saturday, November 29, 2025
730A
Francesco Lavarra Speaker Intravascular Imaging-guided Percutaneous Coronary Intervention
Records:519 Pre[1] [2] [3] [4] [5] [6] [7] [8] [9] [10] Next

http://www.cbsmd.cn Contact us by cbs@cbsmd.cn

Copyright ⓒ CBSMD Nanjing China. All rights reserved.